Literature DB >> 29118264

Accumulation of 5-oxoproline in myocardial dysfunction and the protective effects of OPLAH.

Atze van der Pol1, Andres Gil2, Herman H W Silljé1, Jasper Tromp1,3, Ekaterina S Ovchinnikova1,4, Inge Vreeswijk-Baudoin1, Martijn Hoes1, Ibrahim J Domian5,6, Bart van de Sluis7, Jan M van Deursen8, Adriaan A Voors1, Dirk J van Veldhuisen1, Wiek H van Gilst1, Eugene Berezikov4, Pim van der Harst1, Rudolf A de Boer1, Rainer Bischoff2, Peter van der Meer9.   

Abstract

In response to heart failure (HF), the heart reacts by repressing adult genes and expressing fetal genes, thereby returning to a more fetal-like gene profile. To identify genes involved in this process, we carried out transcriptional analysis on murine hearts at different stages of development and on hearts from adult mice with HF. Our screen identified Oplah, encoding for 5-oxoprolinase, a member of the γ-glutamyl cycle that functions by scavenging 5-oxoproline. OPLAH depletion occurred as a result of cardiac injury, leading to elevated 5-oxoproline and oxidative stress, whereas OPLAH overexpression improved cardiac function after ischemic injury. In HF patients, we observed elevated plasma 5-oxoproline, which was associated with a worse clinical outcome. Understanding and modulating fetal-like genes in the failing heart may lead to potential diagnostic, prognostic, and therapeutic options in HF.
Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29118264     DOI: 10.1126/scitranslmed.aam8574

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  15 in total

Review 1.  A systems approach to clinical oncology uses deep phenotyping to deliver personalized care.

Authors:  James T Yurkovich; Qiang Tian; Nathan D Price; Leroy Hood
Journal:  Nat Rev Clin Oncol       Date:  2019-10-16       Impact factor: 66.675

Review 2.  Pathophysiology and risk factors of peripartum cardiomyopathy.

Authors:  Martijn F Hoes; Zoltan Arany; Johann Bauersachs; Denise Hilfiker-Kleiner; Mark C Petrie; Karen Sliwa; Peter van der Meer
Journal:  Nat Rev Cardiol       Date:  2022-01-11       Impact factor: 49.421

3.  Metabolic modulation predicts heart failure tests performance.

Authors:  Daniel Contaifer; Leo F Buckley; George Wohlford; Naren G Kumar; Joshua M Morriss; Asanga D Ranasinghe; Salvatore Carbone; Justin M Canada; Cory Trankle; Antonio Abbate; Benjamin W Van Tassell; Dayanjan S Wijesinghe
Journal:  PLoS One       Date:  2019-06-20       Impact factor: 3.240

4.  In Vitro Methods to Model Cardiac Mechanobiology in Health and Disease.

Authors:  Ignasi Jorba; Dylan Mostert; Leon H L Hermans; Atze van der Pol; Nicholas A Kurniawan; Carlijn V C Bouten
Journal:  Tissue Eng Part C Methods       Date:  2021-03-05       Impact factor: 3.056

5.  Cardiac foetal reprogramming: a tool to exploit novel treatment targets for the failing heart.

Authors:  A van der Pol; M F Hoes; R A de Boer; P van der Meer
Journal:  J Intern Med       Date:  2020-06-17       Impact factor: 8.989

6.  Metabolomics reveals sex-specific metabolic shifts and predicts the duration from positive to negative in non-severe COVID-19 patients during recovery process.

Authors:  Hong Zheng; Shengwei Jin; Ting Li; Weiyang Ying; Binyu Ying; Dong Chen; Jie Ning; Chanfan Zheng; Yuping Li; Chen Li; Chengshui Chen; Xiaokun Li; Hongchang Gao
Journal:  Comput Struct Biotechnol J       Date:  2021-04-06       Impact factor: 7.271

7.  The Salivary Microbiota, Cytokines, and Metabolome in Patients with Ankylosing Spondylitis Are Altered and More Proinflammatory than Those in Healthy Controls.

Authors:  Longxian Lv; Huiyong Jiang; Ren Yan; Danyi Xu; Kaicen Wang; Qiangqiang Wang; Xiaoxiao Chen; Lanjuan Li
Journal:  mSystems       Date:  2021-06-22       Impact factor: 6.496

8.  Modeling Human Cardiac Hypertrophy in Stem Cell-Derived Cardiomyocytes.

Authors:  Ekaterina Ovchinnikova; Martijn Hoes; Kirill Ustyantsev; Nils Bomer; Tristan V de Jong; Henny van der Mei; Eugene Berezikov; Peter van der Meer
Journal:  Stem Cell Reports       Date:  2018-02-15       Impact factor: 7.765

Review 9.  Treating oxidative stress in heart failure: past, present and future.

Authors:  Atze van der Pol; Wiek H van Gilst; Adriaan A Voors; Peter van der Meer
Journal:  Eur J Heart Fail       Date:  2018-10-19       Impact factor: 15.534

10.  Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression.

Authors:  Xiumeng Hua; Yin-Ying Wang; Peilin Jia; Qing Xiong; Yiqing Hu; Yuan Chang; Songqing Lai; Yong Xu; Zhongming Zhao; Jiangping Song
Journal:  BMC Med       Date:  2020-01-06       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.